| Name | Title | Contact Details |
|---|
OakStar Bank strives to prove each day that banking can and should be a joyful and fun experience. By creating a unique work culture that is rooted and cultivated throughout every aspect of the bank, OakStar team members love what they do, love the people they work with, and love serving the community. The banks commitment to their values and their culture has resulted in the creation of a uniquely new banking experience that is comfortable, warm, and completely relationship based… ultimately a place where customers look forward to going. OakStar Banks passion is to create a positive difference for its customers and leave a long-lasting legacy in the community.
COVE Animal Health is a veterinarian-led network of veterinary hospitals providing integrated primary care, emergency, and specialty services across several states in the Northeastern United States, including Connecticut, Maine, Massachusetts, and Pennsylvania. Originally founded in 1937 as Pieper Veterinary in Middletown, CT, COVE has grown into a multi-state network with over 1,000 team members and four hospital systems. COVE offers a comprehensive range of veterinary services, including routine wellness care, 24/7 emergency services, and advanced specialty care in areas such as internal medicine, ophthalmology, and surgery. The company operates a hub-and-spoke model that ensures seamless coordination among its hospitals, enhancing collaboration and resource sharing. COVE is committed to maintaining local ownership and community connections while fostering a culture of mentorship and professional development for veterinary teams.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Livent produces and distributes lithium raw materials for energy storage, aerospace, pharmaceutical, and polymer industrial applications.
Cox PLLC exists to serve you and your company. We are litigators, counselors and trial attorneys. Our clients hire us to aggressively preserve or grow equity, eliminate risk and resolve disputes. We are available anytime and anywhere.